Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Cusi

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
Journal of Diabetes|August 4, 2018
Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trialPaola Portillo-Sanchez, Fernando Bril, Romina Lomonaco, et al.
Hepatology (Baltimore, Md.)|August 12, 2009
Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitisAmalia Gastaldelli, Stephen A Harrison, Renata Belfort-Aguilar, et al.
Diabetes|September 28, 2002
Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetesMandeep Bajaj, Thongchai Pratipanawatr, Rachele Berria, et al.
Diabetes Care|October 3, 2007
Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanismsMarianella Fernandez, Curtis Triplitt, Estela Wajcberg, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 29, 2025
Pioglitazone reduces hepatic α-1 antitrypsin accumulation through autophagy and AMPK activation in α-1 antitrypsin-deficient miceYuanqing Lu, Regina Oshins, Nesmine R Maptue, et al.
Hepatology (Baltimore, Md.)|April 30, 2014
Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitisFernando Bril, Romina Lomonaco, Beverly Orsak, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 31, 2008
Automatic correction of intensity inhomogeneities improves unsupervised assessment of abdominal fat by MRIVincenzo Positano, Kenneth Cusi, Maria Filomena Santarelli, et al.
Diabetes|May 28, 2005
Dose-response effect of elevated plasma free fatty acid on insulin signalingRenata Belfort, Lawrence Mandarino, Sangeeta Kashyap, et al.
Journal of Hepatology|June 15, 2007
Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitisBogdan Balas, Renata Belfort, Stephen A Harrison, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 20, 2022
Management of NAFLD in primary care settingsVincent W S Wong, Shira Zelber-Sagi, Kenneth Cusi, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
Journal of Diabetes|August 4, 2018
Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trialPaola Portillo-Sanchez, Fernando Bril, Romina Lomonaco, et al.
Hepatology (Baltimore, Md.)|August 12, 2009
Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitisAmalia Gastaldelli, Stephen A Harrison, Renata Belfort-Aguilar, et al.
Diabetes|September 28, 2002
Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetesMandeep Bajaj, Thongchai Pratipanawatr, Rachele Berria, et al.
Diabetes Care|October 3, 2007
Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanismsMarianella Fernandez, Curtis Triplitt, Estela Wajcberg, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 29, 2025
Pioglitazone reduces hepatic α-1 antitrypsin accumulation through autophagy and AMPK activation in α-1 antitrypsin-deficient miceYuanqing Lu, Regina Oshins, Nesmine R Maptue, et al.
Hepatology (Baltimore, Md.)|April 30, 2014
Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitisFernando Bril, Romina Lomonaco, Beverly Orsak, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 31, 2008
Automatic correction of intensity inhomogeneities improves unsupervised assessment of abdominal fat by MRIVincenzo Positano, Kenneth Cusi, Maria Filomena Santarelli, et al.
Diabetes|May 28, 2005
Dose-response effect of elevated plasma free fatty acid on insulin signalingRenata Belfort, Lawrence Mandarino, Sangeeta Kashyap, et al.
Journal of Hepatology|June 15, 2007
Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitisBogdan Balas, Renata Belfort, Stephen A Harrison, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 20, 2022
Management of NAFLD in primary care settingsVincent W S Wong, Shira Zelber-Sagi, Kenneth Cusi, et al.
Pageof 19